“Oral Bioavailability Enhancement of Doxazosin Mesylate: Nanosuspension Versus Self-Nanoemulsifying Drug Delivery Systems”. 2023. ADMET and DMPK 12 (1): 167-76. https://doi.org/10.5599/admet.2022.